Histologic Features and Clinical Outcomes of Lean Metabolic Dysfunction–Associated Steatotic Liver Disease
JAMA · 2026
DOI: 10.1001/jama.2026.18491 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift JAMA, 2026. Verfasst von Leyla de Avila und 59 weiteren Autor:innen. Beteiligte Einrichtung: The Global NASH/MASH Council (GNC), Washington, DC. Hauptthemen laut MEDLINE: Liver, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease, Thinness. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Although metabolic dysfunction–associated steatotic liver disease (MASLD) is traditionally associated with obesity, it is increasingly recognized in individuals with normal weight (ie, lean MASLD).
Objective
To characterize the clinical, histologic, and prognostic features of lean MASLD, and evaluate the performance of noninvasive tests for advanced fibrosis. Design, Setting, and Participants Multinational, retrospective observational study of adults with biopsy-confirmed MASLD from 41 countries from the Global MASLD project. Exposures Lean vs overweight/obese MASLD, defined by body mass index (BMI) and waist circumference. Main Outcomes and Measures Primary outcomes were all-cause mortality and clinical events (hepatocellular carcinoma, hepatic decompensation, liver transplant, death), intermediate outcomes included histologic fibrosis severity, and tests included the Fibrosis-4 (FIB-4) score and liver stiffness measurement (LSM) by transient elastography.
Results
Among 18 326 patients (mean [SD] age, 50.9 [13.1] years; 8714 [47.6%] male), 6.7% were lean by BMI. Among 12 202 patients with waist circumference available, 6.0% were lean by waist circumference (κ = 0.41). Lean MASLD was most prevalent in Asia (11.3% by BMI, 11.7% by waist circumference). Compared with overweight/obese MASLD, lean MASLD had lower prevalence of type 2 diabetes (38.2% vs 48.3%; difference, −10.2% [95% CI, −13.0% to −7.4%]), advanced fibrosis (29.3% vs 37.2%; difference, −7.8% [95% CI, −10.5% to −5.2%]), and Non-Alcoholic Fatty Liver Disease Activity Scores (mean [SD], 3.96 [1.81] vs 4.41 [1.68]; difference, −0.44 [95% CI, −0.56 to −0.33]). The FIB-4 demonstrated lower accuracy for predicting advanced fibrosis (F3-F4) in lean vs overweight/obese MASLD (area under the curve, 0.76 [95% CI, 0.73-0.79] vs 0.79 [95% CI, 0.78-0.80]; difference, −0.03 [95% CI, −0.06 to 0.00]), while LSM had higher accuracy (area under the curve, 0.87 [95% CI, 0.84-0.90] vs 0.83 [95% CI, 0.82-0.84]; difference, 0.04 [95% CI, 0.01-0.07]). Unadjusted rates per 100 person-years in lean vs overweight/obese MASLD were 1.08 vs 0.91 for all-cause mortality and 1.51 vs 1.43 for clinical events, respectively; lean status was not independently associated with all-cause mortality (adjusted hazard ratio [aHR], 0.90 [95% CI, 0.69-1.16]) or clinical events (aHR, 0.94 [95% CI, 0.76-1.17]). Advanced fibrosis (F3-F4) was associated with all-cause mortality (1.46 vs 0.77 per 100 person-years; aHR, 2.10 [95% CI, 1.71-2.57]) and clinical events (3.21 vs 0.89 per 100 person-years; aHR, 3.41 [95% CI, 2.90-4.03]). Conclusions and Relevance Lean MASLD represents a distinct phenotype with milder histologic disease but similar clinical outcomes compared with overweight/obese MASLD. Fibrosis severity, rather than body composition, was associated with prognosis and LSM was reliable in lean individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Global NASH/MASH Council (GNC), Washington, DC.
- Division of Gastroenterology and Hepatology, Department of Medicine, The Medical City for Military and Security Services, Muscat, Oman.
- 1st Academic Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, Laiko General Hospital of Athens, Athens, Greece.
- Section of Gastroenterology, ProMISE Department, University of Palermo, Palermo, Italy.
- Division of Hepatology, Department of Upper GI Diseases, Karolinska University Hospital, Stockholm, Sweden.
- Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of South Korea.
Zitieren
APA
de Avila, L., AlNaamani, K. M., Papatheodoridi, M., Petta, S., Hagström, H., Kim, S. U., Nakajima, A., Crespo, J., Castera, L., Alkhouri, N., Zheng, M. H., Treeprasertsuk, S., Shalimar, Tsochatzis, E., Trivikrama, S. K., Fan, J. G., Roberts, S. K., Alswat, K., Wong, V. W., …, & Stepanova, M. (2026). Histologic Features and Clinical Outcomes of Lean Metabolic Dysfunction–Associated Steatotic Liver Disease. JAMA. https://doi.org/10.1001/jama.2026.18491
Vancouver
de Avila L, AlNaamani KM, Papatheodoridi M, Petta S, Hagström H, Kim SU, et al. Histologic Features and Clinical Outcomes of Lean Metabolic Dysfunction–Associated Steatotic Liver Disease. JAMA. 2026. doi:10.1001/jama.2026.18491
BibTeX
@article{deAvila2026,
author = {de Avila, Leyla and AlNaamani, Khalid M and Papatheodoridi, Margarita and Petta, Salvatore and Hagström, Hannes and Kim, Seung Up and Nakajima, Atsushi and Crespo, Javier and Castera, Laurent and Alkhouri, Naim and Zheng, Ming-Hua and Treeprasertsuk, Sombat and Shalimar and Tsochatzis, Emmanuel and Trivikrama, Shenoy Kotacherry and Fan, Jian-Gao and Roberts, Stuart K and Alswat, Khalid and Wong, Vincent Wai-Sun and Yilmaz, Yusuf and Dunn, Winston and Francque, Sven and Cordie, Ahmed and Yu, Ming-Lung and Ekstedt, Mattias and Goh, George Boon-Bee and Oliveira, Claudia P and Pessoa, Mario Guimaraes and Chan, Wah Kheong and Castellanos Fernandez, Marlen Ivon and Duseja, Ajay and Arab, Juan Pablo and Papatheodoridis, George and Sebastiani, Giada and Villela-Nogueira, Cristiane and D'Ambrosio, Roberta and Lampertico, Pietro and Holleboom, A G and Valsan, Arun and El-Kassas, Mohamed and Kobayashi, Takashi and Kakizaki, Satoru and Caussy, Cyrielle and Pearlman, Brian and Pugliese, Nicola and Vessby, Johan and Choudhary, Narendra Singh and Kawaguchi, Takumi and Russo, Francesco Paolo and Gadano, Adrian and Diaz, Luis Antonio and Singal, Ashwani K and Gunn, Nadege and Mauricio, Didac and Arrese, Marco and Fracanzani, Anna and Lombardi, Rosa and Aghemo, Alessio and Alqahtani, Saleh A and Stepanova, Maria},
title = {Histologic Features and Clinical Outcomes of Lean Metabolic Dysfunction–Associated Steatotic Liver Disease},
journal = {JAMA},
year = {2026},
doi = {10.1001/jama.2026.18491}
}
EUVIMED